Dr. Lisa Christopher-Stine and Dr. Christopher Mecoli with Johns Hopkins Myositis Center joined MSU for a live Q&A webinar...
Featured news, clinical trials, MSU updates and more.
Myositis Support, , Featured, Inclusion Body Myositis (IBM)
Orphazyme's Arimoclomol receives US Fast Track designation in sporadic Inclusion Body Myositis, an incurable rare progressively debilitating muscle-wasting disease...
Choose your language
- Myositis Awareness & Action
- Myositis Empower Walk
- The Grieving Project
- Explore Myositis
- Financial Assistance Program
- #ItsMyTurn: Becoming a Plasma Donor Hero
- Myositis Clinical Trials
- Myositis Webinars
- Upcoming Events
- Donate today!
October 7 @ 7:00 pm - 8:30 pm EDT
October 17 @ 3:00 pm - 4:30 pm EDT
October 30 @ 5:00 pm - 6:30 pm EDT